RxSight, Inc. increased earnings guidance for the full year 2024. For the year, the company expected revenue of $132.0 million to $137.0 million, representing implied growth of 48% to 54% compared to 2023, up from prior guidance of $128.0 million to $135.0 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
58.66 USD | +2.52% | +4.21% | +46.16% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+46.16% | 2.23B | |
-2.05% | 187B | |
+0.45% | 110B | |
-1.80% | 69.54B | |
+13.98% | 46.37B | |
-6.81% | 46.05B | |
+7.97% | 42.54B | |
+18.14% | 30.72B | |
+17.70% | 25.62B | |
-7.55% | 23.32B |
- Stock Market
- Equities
- RXST Stock
- News RxSight, Inc.
- RxSight, Inc. Increases Earnings Guidance for the Full Year 2024